| | | | | | | | | | | | | | | | | | | | | | |
Ownership Document
|
| Schema Version: X0206 |
| Document Type: 3 |
| Period of Report: 10/1/20 |
| No Securities Owned: 0 |
| Issuer: |
| Issuer CIK: 893949 |
| Issuer Name: MEDNAX, INC. |
| Issuer Trading Symbol: MD |
| Reporting Owner: |
| Reporting Owner ID: |
| | Owner CIK: 1468881 |
| | Owner Name: Richards C Marc |
| Reporting Owner Address: |
| | Owner Street 1: 1301 CONCORD TERRACE |
| | Owner Street 2: |
| | Owner City: SUNRISE |
| | Owner State: FL |
| | Owner ZIP Code: 33323 |
| | Owner State Description: |
| Reporting Owner Relationship: |
| | Is Director? No |
| | Is Officer? Yes |
| | Is Ten Percent Owner? No |
| | Is Other? No |
| | Officer Title: EVP, Chief Financial Officer |
| Non-Derivative Table: |
| Non-Derivative Holding: |
| | Security Title: |
| | | Value: Common Stock |
| | Post-Transaction Amounts: |
| | | Shares Owned Following Transaction: |
| Value: 23,498 |
| Footnote ID: F1 |
| | Ownership Nature: |
| | | Direct or Indirect Ownership: |
| Value: D |
| Derivative Table: |
| Derivative Holding: |
| | Security Title: |
| | | Value: Employee Stock Options (right to buy) |
| | Conversion or Exercise Price: |
| | | Value: 16.14 |
| | Exercise Date: |
| | | Value: 9/26/21 |
| | | Footnote ID: F2 |
| | Expiration Date: |
| | | Value: 12/26/23 |
| | | Footnote ID: F2 |
| | Underlying Security: |
| | | Underlying Security Title: |
| Value: Common Stock |
| | | Underlying Security Shares: |
| Value: 192,400 |
| | Ownership Nature: |
| | | Direct or Indirect Ownership: |
| Value: D |
| Footnotes: |
| Footnote - F1: Represents shares of the Issuer's common stock ("Common Stock") granted pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan (the "2008 Plan"). Such shares are fully vested but may not be transferred until the earlier of (i) September 26, 2025 and (ii) the date of the closing of a "Change in Control" of the Issuer (as defined in the 2008 Plan), subject to certain exceptions. |
| Footnote - F2: Option to purchase shares of Common Stock granted pursuant to the 2008 Plan that vests as follows: (A) 61,500 shares are exercisable if and when the Common Stock price closes at $22 per share (or above) for any 40 consecutive trading days before September 26, 2023 ("Performance End Date"); (B) 63,500 shares are exercisable if and when the Common Stock price closes at $25 per share (or above) for any 40 consecutive trading days before the Performance End Date; and (C) 67,400 of the option shares are exercisable if and when the Common Stock price closes at $29 per share (or above) for any 40 consecutive trading days before the Performance End Date; provided, that no option shares will vest prior to September 26, 2021. |
| Remarks: Exhibit 24 - Power of Attorney |
| Owner Signature: |
| Signature Name: /s/ Dominic J. Andreano, Attorney-in-Fact |
| Signature Date: 10/2/20 |
